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ABSTRACT
Microglia represent the resident macrophages of the central
nervous system (CNS) and account for 10% of the adult
glial cell population in the normal brain. Although micro-
glial cells are thought to contribute to most pathological
conditions including CNS infections, neuroinflammatory
lesions, brain tumors, and neurodegenerative diseases,
their exact role in CNS development, homeostasis, and dis-
ease remains poorly understood. In contrast to most macro-
phage populations, microglia survive high-dose ionizing
radiation and maintain themselves locally and independ-
ently of circulating precursors in the steady state. However,
controversies remain on the origin of microglia in the brain
and whether they could potentially be repopulated by circu-
lating myeloid precursors after brain injury. Microglia-
targeted therapies through the use of genetically modified
circulating hematopoietic cells proved to be a promising
therapeutic strategy for the treatment of brain diseases. It
is thus of great importance to understand the contribution
and developmental cues of circulating myeloid cells as
potential microglia progenitors to the adult pool of micro-
glia in the steady state and under inflammatory condi-
tions. VC 2012 Wiley Periodicals, Inc.
HISTORICAL PERSPECTIVE
Glial cells represent all non-neuronal cells in the cen-
tral nervous system (CNS). They were termed glial cells
from the Greek word ‘‘glia’’ meaning glue, to suggest the
‘‘supportive’’ role provided by non-neuronal cells to neu-
ronal cells. Glial cells represent more than 90% of the
human brain and consist of two main populations: the
macroglia, which consist of astrocytes and oligodendro-
cytes, and the microglia.
Pio del Rio-Hortega was the first to distinguish micro-
glia from macroglia and to suggest the mesodermal ori-
gin of these cells in 1932 (del Rio-Hortega, 1932). In this
seminal study, del Rio-Hortega also suggested that
microglia arise early during embryonic development,
which indicates that they might represent a distinct de-
velopmental lineage even though they share many prop-
erties with macrophages in other tissues. Interestingly,
these early studies are still valid today and although it
is now accepted that microglia are derived from myeloid
precursors, the nature of their direct precursor, the time
point at which myeloid precursors first invade the CNS,
and how they are maintained during adult life have
long been a subject of debate. Here, we will discuss
recent developments in our understanding of the ontog-
eny of microglia, which clarified some long-standing
questions on the origin of this unique and distinct cell
population.
MICROGLIA AND THE MONONUCLEAR
PHAGOCYTE SYSTEM
First defined by van Furth et al., the mononuclear
phagocyte system (MPS) refers to highly phagocytic cells
with similar morphology, origin, and function (van Furth
et al., 1972). The MPS theory suggests that most tissue
macrophages derive from circulating monocytes and their
precursors in the bone marrow (BM). Adoptive transfer
studies have shown that circulating monocytes could
potentially give rise to spleen and gut tissue macrophages
(Bogunovic et al., 2009; Geissmann et al., 2003; Varol
et al., 2007). However, increasing evidence in the litera-
ture suggests that tissue phagocytes are more heteroge-
neous than originally assumed.
The best example of the MPS heterogeneity is repre-
sented by the microglial cell. Microglia originate from
primitive macrophages that arise during early develop-
ment and are maintained locally independently of circu-
lating monocytes (see below) (Ginhoux et al., 2010). In
addition to microglia, epidermal Langerhans cells (LCs),
which are the dendritic cells (DC) that populate the epi-
dermis, derive predominantly from fetal liver monocytes
and can also self-renew locally throughout life (Hoeffel
et al., 2012; Merad et al., 2002).
Macrophages also display great diversity in terms of
cytokines and transcription factors necessary for their
development, which can often be ascribed to the tissues
in which they reside. Although it has been suggested
that most tissue macrophages are dependent on the
cytokine macrophage-colony stimulating factor (M-CSF
or Csf-1) for their development, there is now evidence
that microglia and LCs can form in the absence of Csf-1
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ligand (Ginhoux et al., 2006, 2010; Kondo et al., 2007;
Wegiel et al., 1998). In addition, the cytokine GM-CSF
thought to control mostly DC development also controls
lung alveolar macrophage function (Dranoff et al., 1994).
PHENOTYPIC MARKERS
Similar to most tissue macrophages, microglia express
the Csf-1 receptor (Csf-1R also called CD115), the frak-
talkine receptor (Cx3cr1), the glycoproteins F4/80 and
CD68, and the integrin CD11b. The calcium-binding pro-
tein Iba-1 is often used as a marker of microglia,
although similar to the markers above, it is also
expressed by most tissue macrophages and it cannot be
used to differentiate between tissue resident microglia
and other tissue macrophages. Microglia express much
lower CD45 levels than perivascular macrophages in
steady-state conditions, which represents the only phe-
notypical means available to distinguish the two popula-
tions (Table 1 and Fig. 1). The identification of micro-
glia-specific markers would therefore prove extremely
valuable for distinguishing the diverse subsets of mye-
loid cells during neuroinflammatory diseases and to
assess their distinct contributions to brain homeostasis.
TURNOVER OF MICROGLIA IN THE
STEADY STATE
Although it is now accepted that microglia are onto-
genically related to macrophages, the exact contribution
of BM-derived myeloid precursors including monocytes
to the adult microglia pool in the steady state has been
widely debated. In an early study, Ling showed that
adoptive transfer of monocytes labeled with carbon par-
ticles in newborn rats gave rise to labeled microglia in
the brain (Ling, 1979). The use of 3H-thymidine to study
microglia turnover revealed the presence of a low num-
ber of F4/801 and [3H]-thymidine-labeled cells in the
CNS, which increased slowly after isotope injection, sug-
gesting that adult microglia homeostasis results from
both the recruitment of circulating monocytes and local
microglia proliferation (Lawson et al., 1992).
In contrast to most macrophage populations that are
renewed by BM-derived precursors, microglial cells can
survive high-dose g-ray irradiation. These results were
most clearly demonstrated in BM chimeric animals using
congenic markers (CD45.1 and CD45.2) or GFP1 BM cells
(Lassmann and Hickey, 1993; Priller et al., 2001). BM
chimeric animals are generated upon lethal irradiation of
recipient animals followed by their reconstitution with
donor BM cells, which leads to the engraftment of most
circulating as well as tissue leukocytes.
Several groups have suggested that BM-derived mye-
loid cells are constantly recruited to the brain in the
steady state. Priller et al. have shown that upon BM
reconstitution with GFP-transduced BM, GFP1 micro-
glia could be found in the brain parenchyma in a site-
specific manner (Priller et al., 2001). Eight weeks
post-transplant, GFP1 microglia were detected in the
olfactory bulb and the cerebellum (6 and 8% of total
microglia, respectively). Fifteen weeks post-transplant,
GFP1 microglia were detected in the hippocampus
(5.5%) and cerebellum (12.5%) but rarely in the cortex
(2%). Simard and Rivest also detected GFP1 microglia
in many regions of the CNS in wild-type mice trans-
planted with GFP1 BM, 7 weeks after transplant
(Simard and Rivest, 2004). In another study, GFP1 cells
were found only in the cerebellum and in injury sites
(Vallieres and Sawchenko, 2003). In all of these reports,
less than 10–20% of total microglial cells were donor
derived even 1 year after transplant (Ginhoux et al., 2010).
Several reports have also argued against a
replacement of adult microglia by circulating myeloid
TABLE 1. Macrophage Populations in Lymphoid and Nonlymphoid Tissues
CNS Spleen Lymph node Lung Liver
Marker Microglia: Red pulp MF: Subcupsular sinus MF: Alveolar MF: Kupffer cells:
CD45lo CD45hi CD45hi CD45hi CD45hi
F4/801 F4/80hi F4/80lo F4/801 F4/801
CD11b1 CD11bint CD11b1 CD11blo CD11blo
Cx3Cr11 Cx3Cr12 CD1691 SiglecF1 CD1691
CD681 CD11clo CD11chi CD681
Iba-11 Cx3Cr12
Medullary MF: Interstitial MF:
CD45hi CD45hi
F4/801 F4/801
CD11clo CD11c2
CD1691 CD681
MHCII1
References (Ginhoux et al., 2010;
Prinz et al., 2011)
(Hashimoto et al., 2011a;
Kohyama et al., 2009)
(Asano et al., 2011;
Hashimoto et al., 2011a;
Phan et al., 2009)
(Kirby et al., 2009;
Lagranderie et al.,
2003)
(Crocker and Gordon,
1989; Flotte et al.,
1983)
Table summarizes markers of macrophages in the spleen, lymph node, lung, and liver and of microglia in the CNS (Hashimoto et al., 2011b).
Fig. 1. (A) Image depicts Iba-1 staining (microglia) on brain sections
from adult wild-type mice. Bar: 50 lm. (B) Plot shows the percentage of
microglia (CD45loCD11b1F4/801CX3CR11) of adult wild-type mice ana-
lyzed by flow cytometry.
122 GRETER AND MERAD
GLIA
precursors under physiological conditions (Ajami et al.,
2007; Becher et al., 2001; Greter et al., 2005; Mildner et
al., 2007). For example, it has been proposed that donor-
derived microglia identified in BM chimeric animals are
linked to radiation injuries because donor-derived micro-
glial cells were undetectable in BM chimeric animals in
which the brain was protected from irradiation (Mildner
et al., 2007). Similar findings were made in parabiotic
mice. Parabionts are surgically attached mice that share
the same blood circulation for prolonged periods of time
providing a model to assess the physiological turnover of
circulating precursors in the absence of radiation-
induced injuries. Microglia chimerism in parabionts
never exceeded 5–10% (Ajami et al., 2007), even 1 year
post parabiosis (Ginhoux et al., 2010).
We have found that in newborn mice reconstituted
with donor congenic BM cells, less than 5% of microglia
were of donor origin 3 months post-transplant, which is
consistent with the results obtained in adult BM chime-
ras (Ginhoux et al., 2010). Interestingly, however, high
levels of donor microglial chimerism were achieved upon
transplantation of newborn mice deficient of microglia
(PU.12/2 mice, see below) with adult wild-type BM cells
(Beers et al., 2006). This suggests that BM-derived pre-
cursors have the potential to repopulate the empty
microglia niche in the CNS during the perinatal period.
Whether blood-borne precursors could also repopulate
the entire microglial pool in adult mice lacking microglia
remains to be addressed. Taken together, these results
suggest that microglia homeostasis is predominantly
maintained through local self-renewal under physiologi-
cal conditions.
TURNOVER OF MICROGLIA IN
THE INFLAMED STATE
In contrast to the steady state, inflammatory condi-
tions have been thought to promote the recruitment of
circulating myeloid progenitors and their differentiation
into microglia. Mildner et al. showed that Ly6Chi mono-
cytes differentiate into microglia in CNS pathologies
associated with a blood–brain-barrier disruption
(Mildner et al., 2007) (Fig. 2). However, it is difficult to
phenotypically distinguish activated macrophages from
microglial cells in the inflamed CNS, and therefore it
remains possible that donor-derived myeloid cells were
mostly perivascular macrophages or transient micro-
glial-like cells. In addition, it is unclear whether newly
engrafted microglia are functionally and morphologically
equivalent to the resident microglia. A recent study, in
which parabiosis and myeloablation were elegantly com-
bined, revealed that although circulating monocytes
infiltrate the CNS during inflammation, they only give
rise to a transient population of macrophages that disap-
pears once the inflammation resolves (Ajami et al.,
2011). This study also compared the ability of multipo-
tent progenitors contained in the lineage-negative, c-Kit-
positive, Sca-1-positive (KLS) subset and committed my-
eloid progenitors expressing the fraktalkine receptor
CX3CR1 to give rise to long-lived microglia (Ajami et al.,
2011) (Fig. 2). Adoptive transfer of KLS progenitors but
not CX3CR11 progenitors gave rise to detectable levels
of long-lived microglia that persisted during EAE remis-
sion leading the authors to hypothesize that the micro-
glial potential is retained in multipotent progenitors and
lost during commitment to the myeloid lineage. Another
possible explanation is that KLS cells are more resistant
to inflammation-induced injuries compared to committed
progenitors and have a higher proliferation potential,
thereby giving rise to higher levels of committed progen-
itors found in the CX3CR11 fraction.
Mice that carry null mutations in the methyl-CpG-
binding protein (MECP22/2) provide a clinically relevant
model for Rett Syndrome, an X-linked autism spectrum
disorder, characterized in most cases by a mutation of
the MECP2 gene. Interestingly, MECP22/2 microglia
display impaired phagocytic functions and reconstitution
of MECP22/2 animals with wild-type BM cells improved
the clinical symptoms and reduced disease progression
(Derecki et al., 2012). These results revealed a potential
key role for microglia/microglia-like cells in Rett syn-
drome and support the use of BM transplants as a
potential strategy for the treatment of clinical autism
disorders.
Fig. 2. Schematic for the development of microglia. In the steady
state, microglia in the adult CNS are derived from yolk sac primitive
macrophages that arise before E8 and migrate through blood vessels
into the brain. Microglia development is highly dependent on Csf-1R
signaling. During inflammation, circulating Ly6Chi monocytes can give
rise to microglia-like cells in a CCR2-dependent manner or ST-HSC
can differentiate into long-lived microglia directly. (LT-HSC, long-term
hematopoietic stem cells; ST-HSC, short-term hematopoietic stem cells;
CMP, common myeloid progenitor).
123REGULATION OF MICROGLIA DEVELOPMENT AND HOMEOSTASIS
GLIA
Altogether, these studies highlight the importance of
identifying microglial precursors and the mechanistic
cues that control their recruitment to the brain paren-
chyma for the design of novel therapeutic strategies
using myeloid precursors as therapeutic vehicles to
deliver genes into the CNS.
ORIGIN OF MICROGLIA
As described above, congenic BM transplant studies in
newborn mice fail to repopulate microglia in recipient
mice, suggesting that a postnatal wave of circulating
precursors does not contribute to microglial homeostasis
under steady-state conditions establishing that microglia
take residence in the brain before birth. In the mamma-
lian embryo, the first site of hematopoiesis occurs in the
extra-embryonic YS blood islands at around embryonic
age 7.5 (E7.5), which is called primitive hematopoiesis
(Orkin and Zon, 2008). The main function of the primi-
tive hematopoiesis is to generate primitive red blood
cells and macrophages (Lichanska and Hume, 2000;
Lichanska et al., 1999). Primitive hematopoiesis declines
over time and is progressively replaced by definitive
hematopoiesis, which occurs in the aorta-gonad-meso-
nephros region at E10.5 and then later in the fetal liver
starting at E11.5 until birth.
Cuadros et al. were the first to suggest the YS origin
of microglial cells. These early studies used YS chimeras
by grafting a chick embryo with a quail YS and the
usage of histochemical stainings for acid phosphatase to-
gether with antibodies against quail hematopoietic cells.
Their findings indicated that myeloid progenitors invade
the CNS through the pial surface but independently of
blood vessels (Cuadros et al., 1993). The hypothesis that
YS-derived cells give rise to microglia was further sup-
ported by Pessac and coworkers (Alliot et al., 1999).
They demonstrated that microglial precursors, charac-
terized by high expression of F4/801 and CD11b1 and
the capability to adhere to an astroglial monolayer, were
detectable first in the YS and subsequently in the brain
rudiment as early as E8. Similar observations were
made in zebrafish embryos. In this study, macrophage-
like cells differentiated at an early stage (24 h postferti-
lization) in the YS of the zebrafish embryo, which
resembled the YS primitive macrophages of avian and
rodent embryos. These macrophage-like cells were found
in the YS and subsequently migrated to the mesen-
chyme of the head (Herbomel et al. 1999).
Although these early studies suggested that YS mac-
rophages can give rise to microglia, direct evidence of
the YS contribution to adult microglia in vivo remained
unknown. We recently used a fate mapping model to
revisit the contribution of embryonic precursors to adult
microglia. We used a mouse model developed by
Samokhvalov and coworkers (Samokhvalov et al., 2007)
in which mice expressing the tamoxifen-inducible Cre
recombinase under the control of Runt-related transcrip-
tion factor 1 (Runx1) were crossed to ROSA26-stop-
EYFP or ROSA26-stop-LacZ mice (Ginhoux et al., 2010;
Samokhvalov et al., 2007). Runx1 expression is re-
stricted to YS blood islands before E8, whereas after E8
Runx1 is also expressed in definitive hematopoietic pre-
cursors (Samokhvalov et al., 2007). Therefore, a single
injection of tamoxifen before E7.5 leads to the long-term
tagging of early YS cells allowing to trace YS-derived
cells in adult mice. Using this model, we found that ta-
moxifen injection before E7.5 labels 30% of YS macro-
phages (likely because of incomplete Cre-mediated
recombination). Strikingly, analysis of mice at different
time points during development revealed that 30% of YS
labeling was also associated with 30% labeling of micro-
glia in E10 and E13 embryos and 30% labeling of micro-
glial cells in the brain of 6-week-old animals, whereas
no circulating leukocytes and monocytes were labeled in
these mice. Importantly, injection of tamoxifen post-E8.5
failed to label YS macrophages and embryonic microglia
as well as adult microglia, whereas it labeled adult
monocytes and circulating leukocytes (Ginhoux et al.,
2010). These results strongly suggest that microglia that
populate the adult brain derive predominantly from YS
primitive macrophages (Fig. 2). Using mice that are defi-
cient for the sodium–calcium exchanger Ncx1 (Koushik
et al., 2001), which lacks a heartbeat and thus a blood
circulation, we further established that in contrast to
earlier reports, the invasion of YS macrophages into the
brain rudiment is highly dependent on blood vessels
because microglia progenitors fail to enter the brain of
Ncx12/2 mice and rather accumulated in the YS (Gin-
houx et al., 2010). A subsequent study recently estab-
lished that in addition to microglia, a subset of most tis-
sue macrophages also derives from the YS (Schulz et al.,
2012).
TRANSCRIPTION FACTORS AND CYTOKINES
THAT CONTROL MICROGLIA HOMEOSTASIS
AND FUNCTION
Similar to most tissue macrophages, microglia are
highly dependent on Csf-1R for their development (Ham-
ilton, 2008). Csf-1R2/2 mice display greatly reduced
macrophage populations in various tissues and com-
pletely lack microglia (Ginhoux et al., 2010) (Table 2).
Interestingly, Csf1op/op mice that carry a natural null
mutation for Csf-1 (the ligand of Csf-1R) display only
slightly reduced numbers of adult microglia, whereas
macrophages in several tissues are drastically reduced
(Dai et al., 2002; Wiktor-Jedrzejczak et al., 1990). The
requirement for Csf-1R but not Csf-1 in microglia devel-
opment suggested that microglia homeostasis is con-
trolled by an alternative Csf-1R ligand. A new cytokine
called interleukin-34 (IL-34) was recently identified in
mice and humans and was shown to bind Csf-1R with
high affinity (Lin et al., 2008). IL-34 was also found to
support monocyte viability in vitro and to stimulate the
differentiation and proliferation of macrophages reminis-
cent of Csf-1. Expression of IL-34 in a Csf-1-dependent
manner rescued the phenotype of Csf-1-deficient mice
(Wei et al., 2010), suggesting that Csf-1 and IL-34 com-
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parably regulate Csf-1R signaling. However, Csf-1 and
IL-34 display little homology, indicating that they bind
different regions of the Csf-1R (Garceau et al., 2010). IL-
34 is conserved in avian and mammalian species, which
further emphasizes the potential key role of IL-34 in
macrophage biology (Garceau et al., 2010). Interestingly,
IL-34 enhances neuroprotective effects of microglia
in vitro (Mizuno et al., 2011) and is expressed at high
levels in the brain and skin of adult mice, suggesting a
role for IL-34-mediated Csf-1R signaling in these tissues
(Wei et al., 2010). Accordingly, IL-34-deficient mice have
recently been found to have significantly fewer microglia
than wild-type mice (Wang et al., 2012). However, the
fact that IL-34 deficiency does not completely phenocopy
Csf-1R deficiency suggests that Csf-1 might compensate
for the absence of IL-34 in the CNS.
Csf-1R is not only highly expressed by microglia in
adult mice but also by YS macrophages, and the absence
of Csf-1R or Csf-1R blockade compromises microglia dif-
ferentiation in embryos (Ginhoux et al., 2010). It is thus
unclear whether continued Csf-1R expression is required
to promote adult microglia homeostasis in vivo. In addi-
tion, which of the Csf-1R ligands, IL-34 or Csf-1, con-
trols microglia development in embryos and homeostasis
in the adults or whether they have complimentary or
redundant roles remains to be established.
Another key molecule for the development of macro-
phages and microglia is PU.1. PU.1 is an essential tran-
scription factor for adult myelopoiesis and has been
shown to regulate Csf-1R among other genes. PU.1-defi-
cient mice lack macrophages, monocytes, and microglia
(Beers et al., 2006) (Table 2).
The adaptor protein DAP12 or the triggering receptor
expressed on myeloid cells-2 (TREM2) is involved in mye-
loid cell differentiation, and mice deficient in DAP12 or
TREM2 develop osteopetrosis because of the lack of osteo-
clasts (Kaifu et al., 2003; Neumann and Takahashi,
2007). Interestingly, humans with deletions in either of
these genes develop the fatal Nasu-Hakola disease, which
is characterized by bone cysts, bone fractures, and psy-
chotic symptoms leading to severe neurodegeneration and
encephalopathy (Paloneva et al., 2000). A recent study
has shown that Csf-1 activates b-catenin via the adaptor
protein DAP12, which results in proliferation and
survival of macrophages in vitro (Otero et al., 2009).
Interestingly, older mice deficient in DAP12 exhibit fewer
microglia in defined regions of the CNS, for example, in
the basal ganglia and the spinal cord. These findings
established a critical role for DAP12 in the long-term ho-
meostasis of microglia, which might be a direct link to the
pathology of patients with Nasu-Hakola disease.
ANTIGEN PROCESSING FUNCTION AND
PATHOGEN RECOGNITION
In comparison to professional antigen-presenting cells
like DCs, the capacity of microglia to prime na€ıve T cells
is restricted. Similar to macrophages, in the steady
state, microglia express undetectable levels of MHCII
and T-cell costimulatory molecules such as CD40, CD80,
and CD86 and are therefore not properly equipped to
present antigen under physiological conditions (Ran-
sohoff and Perry, 2009). In vitro microglia can rapidly
upregulate these surface molecules in response to
inflammatory stimuli, for example, IFN-g or LPS, and
can activate na€ıve T cells. Their efficiency at inducing T
cell responses, however, is rather limited and poor in
comparison to DCs. Under neuropathological conditions,
microglia instantly convert to an activated state, upreg-
ulate MHCII and costimulatory molecules, and secrete
proinflammatory cytokines such as IL-12, IL-23, TNF-a,
and IL-1b, which are considered essential for the initia-
tion of CNS immunity. Pathogen-associated molecular
patterns are recognized by cells of the innate and the
adaptive immune system through the engagement of
pattern recognition receptors such as Toll-like receptors
or NOD-like receptors. Microglia express all of the nine
TLRs reported to date in mice, which enables them to
sense and respond to a wide variety of pathogens within
the CNS (Lehnardt, 2010). The TLR-induced microglia
activation causes a rapid production of chemokines and
proinflammatory cytokine and the upregulation of
MHCII (Olson and Miller, 2004). However, the excessive
activation of microglia and their release of reactive-oxy-
gen and -nitrogen species and iNOS lead to detrimental
neurotoxic effects, which have to be tightly controlled to
circumvent collateral damage in the CNS. Microglia
express high levels of CX3CR1 (fractalkine receptor),
and it was shown that if microglia are unable to respond
to the ligand CX3CL1 expressed by neurons, neurode-
generation was exacerbated suggesting that the fractal-
TABLE 2. Mice Models Lacking Cells of the MPS
YS
macrophages Monocytes Microglia Macrophages References
Csf-1R ﬂﬂﬂ Ly6Cloﬂﬂﬂ Ly6Chiﬂ ﬂﬂﬂ ﬂﬂﬂ (Dai et al., 2002; Erblich et al., 2011;
Ginhoux et al., 2010; Hashimoto et al., 2011a)
Csf-1 ﬂ ﬂ ﬂ ﬂﬂﬂ (Cecchini et al., 1994; Kondo et al., 2007;
Wegiel et al., 1998; Wiktor-Jedrzejczak et al., 1990)
IL-34 n.d. – ﬂﬂ – (Wang et al., 2012)
Pu.1 ﬂﬂﬂ – ﬂﬂﬂ F4/80hi CD11bloﬂﬂﬂ (Beers et al., 2006; Dakic et al., 2005;
Lichanska et al., 1999; McKercher et al., 1996;
Schulz et al., 2012)
Myb – n.d. – F4/80lo CD11bhiﬂﬂﬂ (Schulz et al., 2012)
DAP12 n.d. – ﬂ n.d. (Otero et al., 2009)
Table summarizes phenotypes of mice lacking transcription factors or cytokines.
n.d., not determined; -, no difference compared to wild-type mice; ﬂ, reduction compared to wild-type mice.
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kine receptor modulates microglia neurotoxicity (Car-
dona et al., 2006). Another example for a neuron-micro-
glia-inhibitory signal is CD200-CD200R. CD200 is
expressed by neurons, whereas CD200R is expressed by
microglia. In CD200-deficient mice, microglia exhibit an
activated phenotype under physiological conditions and
an accelerated response to facial nerve transection and
an earlier disease onset in EAE (Hoek et al., 2000).
MICROGLIA AND EPIDERMAL
LANGERHANS CELLS
LCs are the resident DCs of the epidermis and repre-
sent the first immune line of defense against skin-invad-
ing pathogens. Interestingly, LCs resemble microglia
in several aspects. Similar to microglia, LCs express
high levels of Csf-1R, and mice lacking Csf-1R are com-
pletely devoid of LCs (Ginhoux et al., 2006). In contrast,
Csf1op/op mice display normal numbers of LCs (Ginhoux
et al., 2006; Wiktor-Jedrzejczak et al., 1990). This was
explained by a recent study demonstrating that IL-34-
mediated Csf-1R signaling is critical for the development
of LCs (Wang et al., 2012). Like microglia, LCs are ra-
dio-resistant, maintain themselves in situ, and are not
repopulated by blood-borne precursors during the steady
state (Merad et al., 2002). So far, LCs and microglia are
the only known hematopoietic cell types capable of self-
renewal during homeostatic conditions. Upon severe skin
inflammation, however, the resident LCs disappear and
are reconstituted by Ly6Chi monocytes in a Csf-1R-
dependent manner (Ginhoux et al., 2006). Recent studies
established that LC predominantly derive from fetal liver
monocytes with some minor contribution from YS macro-
phages (Ginhoux and Merad, 2010; Hoeffel et al., 2012).
FUNCTIONAL RELEVANCE OF THE
ONTOGENY DATA
Ample evidence now suggests that microglia form a
separate developmental lineage of the MPS. Certain
aspects of microglia ontogeny and their developmental
requirements, for example, Csf-1R dependency, have been
resolved. However, the precise underlying mechanisms for
their homeostasis in healthy adult life as well as during
pathologies remain unclear. Microglia play multifaceted
roles not only during physiological conditions in embryonic
as well as adult neurogenesis but also during CNS patholo-
gies such as in neuroinflammation, neurodegeneration,
and neural repair. Many neuroinflammatory diseases are
characterized by microgliosis concomitant with the infiltra-
tion of blood-derived myeloid cells. Discriminating invad-
ing myeloid cells from resident microglia will be helpful for
designing new therapeutic strategies for the treatment of
CNS pathologies. The identification of YS-derived micro-
glia-specific genes that are absent from newly engrafted
microglia-like cells and CNS-associated macrophages
should allow the specific targeting of tissue resident micro-
glia and gain a better understanding of the homeostatic
mechanisms and the functional specialization of this criti-
cal brain support system.
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